I am still a bit bemused by the wording of the announcement.
”FDA has informed the company that following additional consideration the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission”
Note - not “data”, not “new information”, but “consideration”.
Were the FDA head honchos having a round of golf, and decided amongst themselves that they had been a bit hard on the Aussie battler? Then back to the clubhouse for a scotch or three.
Or perhaps Big Pharma have “advised” the FDA top order that Meso's gonads have been squeezed enough, so give them a win that also allows BP to make a cheap TO?
Don't get me wrong. My wife is very happy to see the reverse in fortunes, and so quick after that dilutive capital raise too!
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-451
-
- There are more pages in this discussion • 336 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.13 |
Change
-0.098(7.93%) |
Mkt cap ! $1.287B |
Open | High | Low | Value | Volume |
$1.20 | $1.20 | $1.12 | $11.63M | 10.08M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
39 | 95477 | $1.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.14 | 78279 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 89401 | 1.130 |
29 | 489940 | 1.125 |
27 | 227240 | 1.120 |
13 | 99029 | 1.115 |
15 | 185741 | 1.110 |
Price($) | Vol. | No. |
---|---|---|
1.135 | 59837 | 15 |
1.140 | 88758 | 13 |
1.145 | 220140 | 13 |
1.150 | 109728 | 9 |
1.155 | 85263 | 6 |
Last trade - 15.24pm 30/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.13 |
  |
Change
-0.098 ( 8.47 %) |
|||
Open | High | Low | Volume | ||
$1.20 | $1.20 | $1.12 | 1520180 | ||
Last updated 15.40pm 30/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin & Ramón Jiménez Serrano, Managing Director & Executive Director
Ryan Parkin & Ramón Jiménez Serrano
Managing Director & Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online